ANGO: Angiodynamics Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
161 institutions reported holding $489.19M of Angiodynamics Inc on Form 13F (147 the quarter before). 29 opened a new position and 15 sold out. Shares held by institutions: -1%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 3,803,232 | $49.48M |
| Point72 Asset Management, L.P. | 3,062,517 | $39.84M |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 2,640,214 | $34.35M |
| ARMISTICE CAPITAL, LLC | 2,198,000 | $28.60M |
| ROYCE & ASSOCIATES LP | 1,969,835 | $25.63M |
| Broadfin Holdings LLC | 1,818,533 | $23.66M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,694,716 | $22.05M |
| WEBER CAPITAL MANAGEMENT LLC /ADV | 1,356,602 | $17.65M |
| Nuveen, LLC | 1,199,358 | $15.60M |
| GEODE CAPITAL MANAGEMENT, LLC | 1,020,658 | $13.28M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.